Introduction
============

Ozone (O~3~) is formed by the photochemical reaction of sunlight with nitrogen oxides, facilitated by the presence of a variety of volatile organic compounds. Natural background concentrations of ground-level ozone are typically around 30--100 μg/m^3^. However, short-term (1-hr) mean ambient concentrations in urban areas may exceed 300--800 μg/m^3^ ([@r52]). Both natural and anthropogenic sources contribute to the emission of ground-level O~3~ precursors, and the composition of emissions may show large variations across locations ([@r51]). Motor vehicles are the main anthropogenic sources of ground-level O~3~ precursors ([@r16]; [@r44]).

A large volume of information on the health impacts of ground-level ozone is derived from animal studies, whereas a more limited number of investigations have concentrated on population and controlled human studies focused on short-term exposures. Clinical studies on asthmatic and nonasthmatic adults have demonstrated that acute exposure to O~3~ results in decreases in lung function, enhanced allergen-induced bronchoconstriction, and increases in airway inflammation typified by an influx of neutrophils ([@r3], [@r4], [@r5]; [@r24]; [@r26]; [@r28]). Similarly, short-term exposure to elevated levels of O~3~ leads to an early inflammatory response characterized by neutrophil accumulation in several animal models ([@r19]; [@r30]; [@r44]; [@r58]).

Interleukin 8 (IL-8) is a potent neutrophil activator and chemotaxin that is often used as a biological marker of environmentally induced pulmonary inflammation ([@r32]; [@r45]). O~3~ inhalation induces airway epithelial damage and increased release of proinflammatory mediators, including IL-8, in human bronchoalveolar lavage fluid ([@r10]; [@r31]). *In vitro* exposure to O~3~ has been shown to induce IL-8 production in human bronchial epithelial cells (HBEC) ([@r8]; [@r16]; [@r42]). However, the mechanisms that regulate O~3~-induced IL-8 expression have not been fully elucidated.

The expression of the *IL-8* gene in HBEC is known to be regulated through both message stabilization and transcriptional activation that is modulated by signaling pathways that include growth factor receptors ([@r29]; [@r45]). The activation of the epidermal growth factor receptor (EGFR) is a pivotal event in normal and pathophysiological conditions leading to the initiation of multiple signaling pathways that lead to alterations in gene expression ([@r46]). EGFR is a single transmembrane protein that possesses intrinsic tyrosine kinase activity, which can be directly activated or transactivated in response to a variety of stimuli ([@r22]). The cytoplasmic region of human EGFR contains an intrinsic tyrosine kinase (697--955) followed by a 231-residue-long COOH-terminal tail, which contains multiple tyrosine residues that function as phosphorylation sites ([@r56]). Five sites of *in vivo* autophosphorylation have been identified in the EGFR: three major sites (tyrosines 1068, 1148, and 1173) and two minor sites (tyrosines 992 and 1086) ([@r18]; [@r35]). The binding of phosphorylated EGFR tyrosines with downstream signaling proteins initiates the simultaneous activation of multiple signaling cascades that culminate in a broad range of cellular responses spanning proliferation, migration, protein secretion, differentiation, and oncogenesis ([@r50]).

Previous studies have demonstrated that epithelial expression of the EGFR and its ligands, including EGF and transforming growth factor α, were all significantly increased in nasal biopsy specimens collected following O~3~ exposure of human volunteers, suggesting a positive correlation between EGFR expression and the increase in neutrophil numbers in the nasal epithelium ([@r39]). Another study using human epidermal keratinocytes showed that exposure to O~3~ resulted in increased phosphorylation of EGFR ([@r1]). In the present study, we investigated the effect of O~3~ stimulation on EGFR phosphorylation and its relationship with IL-8 expression in HBEC. We report here that the cytosolic tyrosine kinase Src can regulate EGFR activity, further modulating O~3~-induced IL-8 expression.

Materials and Methods
=====================

*Reagents*. Bis\[sulfosuccinimidyl\]suberate (BS3), PP2, and bosutinib (the latter two being Src kinase inhibitors) and compound 56 (C56; an EGFR inhibitor) were obtained from Calbiochem (San Diego, CA, USA). The rabbit antibodies against phospho (p)-EGFR (Y1068), p-EGFR (Y845), p-Src(Y416), pan-EGFR, and pan-Src were purchased from Cell Signaling Technology (Beverly, MA, USA). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The lactate dehydrogenase (LDH) cytotoxicity detection kit was obtained from TAKARA Bio Inc. (Mountain View, CA, USA), and the IL-8 ELISA assay kit was purchased from eBioscience (San Diego, CA, USA).

*Cell culture and O~3~ exposure*. The BEAS-2B cell line was derived by transforming HBEC with an adenovirus 12-simian virus 40 construct ([@r40]). BEAS-2B cells (passages 70--80) were cultured in supplemented keratinocyte basal medium as described previously ([@r53]). The cells were placed in 6-well culture plates (Costar, Cambridge, MA, USA) and grown to confluence.

Normal human bronchial epithelial (NHBE) cells were obtained from normal adult human volunteers by brush biopsy of the mainstem bronchus using a cytology brush during fiberoptic bronchoscopy; the procedure was conducted under a protocol approved by the Committee on the Protection of the Rights of Human Subjects at the University of North Carolina at Chapel Hill. Human participants gave written informed consent prior to the study. NHBE cells were initially plated in supplemented bronchial epithelial cell basal medium ([@r48]). Confluent cells were split and placed on the Transwell® permeable supports (Corning, Tewksbury, MA, USA) for air--liquid interface (ALI) culture before O~3~ exposure.

A431 cells were obtained from the Lineberger Cancer Center Tissue Culture Facility at the University of North Carolina at Chapel Hill. A431 cells were cultured on plastic flasks in Dulbecco's minimum essential medium with high glucose supplemented with 10% fetal bovine serum and gentamicin (5 μg/mL).

Prior to exposure of BEAS-2B or A431 cells, 0.5 mL of media was placed in each well of the 6-well plates. In some experiments, BEAS-2B cells were pretreated with 1 μM C56, 10 μM PP2, or bosutinib (5 or 10 μM) for 30 min before O~3~ exposure. After exposure, the cells were lysed and the cell lysates subjected to immunoblotting for measurement of p-EGFR (Y1068), or p-EGFR (Y845). The supernatants of cell medium were collected for measurement of IL-8 protein. Exposure to O~3~ or clean air was conducted using a rotating inclined platform in specially designed *in vitro* exposure chambers operated by the U.S. Environmental Protection Agency Environmental Public Health Division as described previously ([@r16]). The exposure atmosphere contained 5% CO~2~; the relative humidity was maintained at \> 95%; and the temperature was 37°C throughout the exposure. Conditions in the air control chamber were identical except for the absence of O~3~.

In the case of the ALI-cultured NHBE, the cells were exposed without media on the apical surface without rotation of the platform. Air controls were run simultaneously in an identical duplicate chamber in which no ozone was introduced.

*Analysis of EGFR dimerization*. The EGFR dimerization assay was performed according to a previously described method ([@r43]). Briefly, subconfluent cells deprived of serum for 12--18 hr were exposed to 1 ppm O~3~ or air alone (control) for 30 min in an O~3~ exposure chamber as described above. After this exposure, cells were incubated with 10 ng/mL EGF for 5 min. The cells were then treated with 2.5 mM crosslinker BS3 in phosphate-buffered saline (PBS) for 30 min at room temperature. The cross-linking reaction was stopped by incubating cells with PBS containing 20 mM Tris, pH 7.5, for 15 min. The cells were then scraped into 1 mL of PBS, and protein extracts were prepared and subjected to immunoblotting using a mouse anti-human EGFR antibody cocktail (Neomarkers, Fremont, CA, USA) that recognizes the extracellular domain of the EGFR.

*Immunoblotting*. The cells exposed to 0.25--1.0 ppm O~3~ for 0--120 min were washed twice with ice-cold PBS and then lysed in RIPA buffer as described previously ([@r53]). The supernatants of cell lysates were subjected to SDS-PAGE analysis. Proteins were transferred onto nitrocellulose membrane, which was then blocked with 5% nonfat milk, washed briefly, incubated with primary antibody at 4°C overnight, and then incubated with the corresponding HRP-conjugated secondary antibody for 1 hr at room temperature. Immunoblot images were detected using chemiluminescence reagents and a Fujifilm LAS-3000 imaging system (Fuji Medical Systems USA, Stamford, CT, USA), and the images were digitized for quantification using MultiGauge v3.1 software (Fuji Medical Systems USA). The optical density (OD) of the phosphor-specific band was expressed as a fraction (% P) of the total OD (i.e., phospho + non-phospho bands) for the species of interest.

*ELISA (enzyme linked immunosorbent assay).* After exposure to 1 ppm O~3~ for 2 hr, cell culture media were collected and centrifuged. Levels of IL-8 protein in the supernatants were measured using an IL-8 ELISA assay kit following the manufacturer's instructions (eBiosciences, San Diego, CA, USA).

*Statistical analysis*. Data are presented as mean ± SE. Data comparisons were carried out using one-way analysis of variance (ANOVA) followed by Dunnett's post-test and two-tailed Student's *t*-test, with the overall α level set at 0.05.

Results
=======

*O~3~ exposure and induction of phosphorylation of EGFR (Y1068) in HBEC*. Preliminary experiments determined O~3~ concentrations and exposure times that did not result in significant cytotoxicity, as determined by LDH release (data not shown). Phosphorylation of EGFR is an indicator of its activation. O~3~-induced EGFR phosphorylation has been shown previously in human skin cells ([@r1]). Here, we examined whether O~3~ exposure could affect EGFR phosphorylation in HBEC. As shown in [Figure 1A,B](#f1){ref-type="fig"}, O~3~ exposure induced a concentration- and time-dependent increase in EGFR phosphorylation at tyrosine 1068 (Y1068) in BEAS-2B cells. Exposure to O~3~ was also observed to increase EGFR (Y1068) phosphorylation in ALI-cultured primary HBEC, demonstrating that this effect of O~3~ is not limited to transformed cells ([Figure 1C](#f1){ref-type="fig"}).

![Effect of O~3~ exposure on phosphorylation of EGFR (Y1068) in HBEC. (*A*) BEAS-2B cells grown to confluence were exposed to 1 ppm O~3~ for 0--120 min. (*B*) BEAS-2B cells grown to confluence were exposed to various concentrations of O~3~ for 2 hr. (*C*) NHBE cells were cultured in an ALI system and exposed to 1 ppm O~3~ for 30 min. In each case (*A--C*), protein was extracted from the cells and subjected to SDS-PAGE followed by immunoblotting using a phospho-specific anti-EGFR antibody and then a pan-EGFR antibody. %P indicates the optical density of the p-EGFR band as a fraction of the total EGFR signal (p-EGFR + EGFR). Data shown are representative of three separate experiments.](ehp.1307379.g001){#f1}

*O~3~ exposure and induction of EGFR dimerization*. The finding that O~3~ exposure induces the phosphorylation of EGFR at the putative autophorylation site Y1068 ([@r18]) suggested the possibility that O~3~ activates the receptor through a mechanism that mimics ligand binding of the extracellular domain on the EGFR. To investigate this potential mechanism of activation of O~3~-induced EGFR, we measured EGFR dimerization, a marker of ligand-dependent activation of the EGFR, in the EGFR overexpressing cell line A431. As shown in [Figure 2](#f2){ref-type="fig"}, relative to the air-treated control, treatment of A431 cells with the natural ligand EGF induced dimerization of EGFR within 5 min. In marked contrast, EGFR dimerization was not detectable in A431 cells exposed to 1 ppm O~3~ for 30 min, indicating that O~3~ exposure did not cause EGFR activation through a ligand-like mechanism.

![O~3~ exposure and EGFR dimerization in A431 cells. Confluent A431 cells were exposed to air (control) or 1 ppm O~3~ for 30 min, or to 10 ng/mL EGF for 5 min. The cells were then exposed to saline or the cross-linking agent BS3, and total protein extracts were extracted and subjected to Western blotting using anti-EGFR antibody.](ehp.1307379.g002){#f2}

*O~3~ exposure and induction of Src-​dependent phosphorylation of the EGFR in HBEC*. We next examined the potential of EGFR activation through transphosphorylation by a kinase intermediate. We have shown previously that cytosolic tyrosine kinase Src is involved in EGFR transactivation in HBEC exposed to another oxidant stressor ([@r54]). Therefore, we examined the role of Src kinase in O~3~-induced EGFR phosphorylation by first determining the effect of O~3~ exposure on phosphorylation of Src at tyrosine 416, a specific activation site in the SH1 domain of c-Src ([@r17]), in O~3~-exposed BEAS-2B cells. Exposure to 0.25--1.0 ppm O~3~ for 120 min induced a concentration-dependent increase in the phosphorylation of Src (Y416) ([Figure 3A](#f3){ref-type="fig"}). In addition, a time-dependent increase in Src (Y416) phosphorylation was observed in response to exposure to 1 ppm O~3~ ([Figure 3B](#f3){ref-type="fig"}).

![O~3~ exposure and phosphorylation of Src (Y416) in BEAS-2B cells. BEAS-2B cells grown to confluence were exposed to various concentrations of O~3~ for 2 hr (*A*) or to 1 ppm O~3~ for 0--30 min (*B*). In each case, protein was extracted from the cells and subjected to SDS-PAGE followed by immunoblotting using a phospho-specific anti-Src (Y416) antibody and then a pan-Src antibody. %P indicates the optical density of the p-Src band as a fraction of the total Src signal (p-Src + Src). Data shown are representative of three separate experiments.](ehp.1307379.g003){#f3}

Tyrosine 845 on the EGFR has been reported to be a site of transphosphorylation by Src kinase ([@r49]). As shown in [Figure 4A](#f4){ref-type="fig"}, exposure to 0.25--1.0 ppm O~3~ for 120 min induced phosphorylation of EGFR (Y845), an effect that was ablated by pretreatment of the cells with the Src kinase inhibitor PP2 ([Figure 4B](#f4){ref-type="fig"}). Similarly, inhibition of Src kinase activity also blunted O~3~-induced phosphorylation of EGFR at Y1068 in NHBE cells ([Figure 4C](#f4){ref-type="fig"}). Pretreatment of BEAS-2B cells with the structurally unrelated Src kinase inhibitor bosutinib corroborated these findings (see Supplemental Material, Figure S1). We previously observed that exposure to Zn^2+^ induced Src-dependent phosphorylation of EGFR ([@r54]). As we expected in the present study, Src inhibition with bosutinib effectively reduced Zn^2+^-induced phosphorylation of EGFR in BEAS-2B cells (see Supplemental Material, Figure S2). Taken together, these data implicated Src kinase in O~3~-induced EGFR transactivation at both transphosphorylation and autophosphorylation sites in HBEC.

![Src kinase and O~3~-induced phosphorylation of EGFR in HBEC. (*A*) BEAS-2B cells grown to confluence were exposed to various concentrations of O~3~ for 2 hr. BEAS-2B cells (*B*) or ALI-cultured NHBE cells (*C*) were pretreated with vehicle (0.1% DMSO) or the Src kinase inhibitor PP2 (10 μM) for 30 min prior to exposure to 1 ppm O~3~ for 1 hr. In each case (*A--C*), protein was extracted from the cells and subjected to SDS-PAGE followed by immunoblotting using phospho-specific EGFR antibodies and then a pan-EGFR antibody. %P indicates the optical density of the p-EGFR band as a fraction of the total EGFR signal (p-EGFR + EGFR). Data shown are representative of three separate experiments.](ehp.1307379.g004){#f4}

*EGFR kinase--dependent EGFR (Y1068) phosphorylation in O~3~-exposed HBEC*. Previous studies have shown that phosphorylation of EGFR (Y1068) can occur in the presence or absence of EGFR kinase activity ([@r38]; [@r55]). To determine whether Src-mediated EGFR (Y1068) phosphorylation is EGFR kinase-dependent, we pretreated BEAS-2B cells ([Figure 5A](#f5){ref-type="fig"}) or ALI-cultured primary HBEC ([Figure 5B](#f5){ref-type="fig"}) with vehicle (0.1% DMSO) or the specific EGFR kinase activity inhibitor C56 (1 μM) for 30 min before exposure to 1 ppm O~3~ for 1 hr. As shown in [Figure 5](#f5){ref-type="fig"}, inhibition of EGFR kinase activity in HBEC abrogated O~3~-induced EGFR (Y1068) phosphorylation, implying that O~3~-induced phosphorylation of EGFR at Y1068 requires the intrinsic kinase activity of the EGFR.

![Abrogation of O~3~-induced phosphorylation of EGFR (Y1068) is by the EGFR inhibitor C56. BEAS-2B cells (*A*) or ALI-cultured NHBE cells (*B*) were pretreated with vehicle (0.1% DMSO) or C56 (1 μM) for 30 min before exposure to 1 ppm O~3~ for 1 hr. Cells were lysed, and phosphorylation of EGFR (Y1068) was determined as described in "Materials and Methods." Data shown are representative of three separate experiments.](ehp.1307379.g005){#f5}

*Requirement of EGFR and Src kinase activities for O~3~-induced IL-8 expression in HBEC*. Previous studies have shown that exposure to O~3~ results in increased expression of proinflammatory mediators, including IL-8 in HBEC ([@r8]; [@r16]; [@r25]; [@r37]). To determine the roles of EGFR and Src activation in proinflammatory response of HBEC to O~3~ exposure, we examined the effect of EGFR or Src inhibition on O~3~-induced IL-8 expression in BEAS-2B cells. As shown in [Figure 6](#f6){ref-type="fig"}, pretreatment of BEAS-2B cells with either an EGFR or Src kinase activity inhibitor was able to abrogate IL-8 expression induced by exposure to 1 ppm O~3~ for 2 hr.

![Effects of C56 and PP2 on O3-induced IL-8 expression in BESA-2B cells. BEAS-2B cells were pretreated with vehicle (0.1% DMSO), PP2 (10 μM), or C56 (1 μM) for 30 min before exposure to 1 ppm O~3~ for 2 hr. Culture media were collected, and IL-8 protein was examined in the supernatants using ELISA. \**p* \< 0.05 (*n* = 3) compared with matched air controls, by Student's *t*-test.](ehp.1307379.g006){#f6}

Discussion
==========

The mechanisms for the transactivation of EGFR vary with the cell type and stimulus. Previous studies have shown that EGFR is involved in signaling networks activated by a number of stimuli that do not interact directly with this receptor ([@r11]). These stimuli include G protein--coupled receptor agonists ([@r13]), calcium ([@r15]), and ultraviolet irradiation ([@r14]). The results of the present study show that O~3~ exposure transactivates EGFR through a mechanism that depends on the activation of the cytosolic tyrosine kinase Src, leading to elevated expression of IL-8.

The dependency of O~3~-induced EGFR activation on Src activation in HBEC is supported by the findings of O~3~-induced phosphorylation of Src at Y416, the phosphorylation of EGFR at the transactivation site Y845, and the inhibitory effect of Src kinase inhibitors on EGFR phosphorylation. The mechanisms involved in O~3~-induced Src activation are currently unknown. In a previous study, we observed that O~3~ exposure induced reactive oxygen species (ROS) production in BEAS-2B cells ([@r53]). Thus, O~3~-induced excessive production of ROS and nitrogen intermediates ([@r27]) might be able to modify tyrosine residues, altering phosphorylation of many protein kinases involved in cell signalling ([@r2]). Another mechanism underlying O~3~-induced Src activation may involve loss of homeostatic phosphatase activity. We previously observed that loss of protein tyrosine phosphatase (PTP) activity was responsible for the initiation of EGFR signaling in HBEC exposed to zinc or diesel exhaust particles ([@r48], [@r47]). PTPs are redox-sensitive proteins; their active-site cysteines are the targets of specific oxidation by various oxidants ([@r21]). In this regard, our observation that another electrophilic insult, Zn^2+^, can induce Src-dependent EGFR transphosphorylation ([@r54]) is consistent with our previous report of Zn^2+^-induced inhibition of PTPs ([@r48]), and may reflect a uniform mechanism to oxidant stress that is also relevant to other environmental electrophiles. Additional studies will be required to investigate the role of PTP activity in O~3~-induced activation of Src leading to EGFR activation and IL-8 expression.

EGFR (Y845) is particularly interesting because of its location within the activation loop of the tyrosine kinase domain of the EGFR. This tyrosine residue is highly homologous to tyrosines that are sites of autophosphorylation found in the kinase domains of other tyrosine kinases that have been shown to be critical to their activation ([@r9]). Unlike the tyrosines in these other kinases, EGFR (Y845) is not an autophosphorylation site and does not need to be phosphorylated for the kinase to be active ([@r49]). However, phosphorylation of EGFR (Y845) has been proposed as a direct substrate of Src ([@r49]). Our previous study ([@r54]) demonstrated that mutating this tyrosine to a nonphosphorylatable phenylalanine led to an abrogation of zinc-induced Ras activation in fibroblasts. In a separate study we observed that the Src kinase inhibitor PP2 significantly blocked zinc-induced phosphorylation of EGFR (Y845) in A431 cells ([@r43]). Similarly, in the present study PP2 or bosutinib pretreatment markedly inhibited O~3~-induced EGFR (Y845) phosphorylation. Taken together, these data suggest that EGFR (Y845) phosphorylation is critical to EGFR/c-Src synergy and cross talk.

Nevertheless, there is also evidence to suggest that EGFR (Y845) is not the only target site for Src kinase. For example, a study in A431 cells showed that zinc ions can induce phosphorylation of EGFR (Y1068) and EGFR (Y845) that is Src dependent but EGFR kinase independent ([@r43]). [@r6] demonstrated that Src kinase is required for phorbol 12-myristate 13-acetate--induced EGFR (Y1068) phosphorylation using PP2 and siRNA against c-Src. These studies suggest that Src kinase can directly phosphorylate EGFR (Y1068). In contrast, the present study indicates that Src-regulated EGFR (Y1068) phosphorylation is mediated by EGFR kinase because the EGFR kinase inhibitor C56 significantly blocked O~3~-induced EGFR (Y1068) phosphorylation in BEAS-2B cells. Thus, we infer that O~3~ stimulation first activates Src, which in turn causes EGFR (Y845) phosphorylation. Phosphorylated EGFR (Y845) located in the EGFR kinase domain facilitates the modification of EGFR kinase domain conformation, leading to its activation and the subsequent autophosphorylation of EGFR (Y1068). This hypothesis could be examined using cells expressing kinase-inactive or Y845-mutated EGFR. In addition, oxidative stress has been reported to induce ligand-independent EGFR activation through a conformational modification of the intracellular kinase domain under conditions in which the c-Src is physically bound to EGFR ([@r20]). In addition, the extreme reactivity of O~3~ may have led to an underestimation of cytotoxicity in the present study, leaving open the possibility that the initiation of signaling is secondary to the induction of cellular injury. Additional studies will be required to test these possible mechanisms of EGFR activation in O~3~-exposed HBEC.

EGFR has been shown to be involved in signaling leading to increased IL-8 production by human airway epithelial cells in chronic inflammatory airway diseases ([@r23]; [@r41]). In the present study we observed that Src-regulated EGFR activation was necessary for O~3~-induced IL-8 expression in HBEC. Additional mechanisms involved in O~3~-induced EGFR activation leading to IL-8 remain to be elucidated. The traditional cytoplasmic EGFR-initiated route involves transduction of mitogenic signals through activation of several signaling cascades, such as phospholipase Cγ, protein kinase C, mitogen-activated protein kinases, phosphatidylinositol-3-kinase, and signal transducer and activator of transcription (STATs) ([@r7]; [@r12]; [@r34]; [@r36]). In the nuclear pathway, activated EGFR undergoes fast nuclear translocation, where it physically or functionally interacts with other transcription factors possessing DNA-binding activity and STAT3, leading to up-regulation of genes involved in a host of cellular responses that include IL-8 expression ([@r33]; [@r34]; [@r57]).

Conclusion
==========

Our findings indicate that exposure to O~3~ resulted in Src-dependent EGFR activation leading to a proinflammatory response that included IL-8 expression in human airway epithelial cells. Given that O~3~ exposure is a widespread public health concern, characterization of the mechanisms underlying O~3~-induced airway inflammation will yield insights useful in the design of preventive and therapeutic interventions.
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=====================
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